The 20 Best Lung Metastases Doctors Near Me in Essex, MD

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis. Dr. Wise is board certified in American Board Of Internal Medicine.

Dr. Danoff is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine and Co-Director of the Hopkins Interstitial Lung Disease Clinic. She is a specialist in diseases causing fibrosis or scarring in the lung, particularly those associated with autoimmune diseases including myositis. Dr. Danoff is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Lung Transplant, and Endoscopy. Dr. Danoff is board certified in American Board Of Internal Medicine.

Dr. Sarath Raju is an instructor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include obstructive lung diseases (asthma, chronic obstructive pulmonary disease), chronic lung disease in persons living with HIV, and critical care medicine. Dr. Raju earned his M.D. from Rush Medical College. He completed his residency at Johns Hopkins, where he also performed a fellowship in pulmonary and critical care medicine. He previously served as an Assistant Chief of Service for the Osler Medical Housestaff Training Program at Johns Hopkins. Dr. Raju joined the Johns Hopkins faculty in 2020, and is supported by the NIH to conduct research investigating the intersection of HIV, environmental exposures, and lung health. Dr. Raju is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Bronchogenic Cyst, Lung Metastases, Bronchitis, and Endoscopy. Dr. Raju is board certified in American Board Of Internal Medicine.

Dr. McCormack is a pulmonary, critical care physician and Associate Director of the Pulmonary & Critical Care Medicine Division. She is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. She has expertise in pulmonary physiology. She serves as the Medical Director of the Johns Hopkins University Pulmonary Function Laboratory and as the Chair of the American Thoracic Society Pulmonary Function Test Committee. She earned her M.D. from Jefferson Medical College of Thomas Jefferson University and her M.H.S. from the Bloomberg School of Public Health. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. She was the recipient of the Frederick L. Brancati Excellence in Mentoring Award. She plays an active role in mentoring fellows and junior faculty in the Pulmonary & Critical Care Medicine Division. Dr. Mccormack is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Asthma, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant. Dr. Mccormack is board certified in American Board Of Internal Medicine.

Dr. Chen practices Pulmonary and Critical Care Medicine. His primary area of interest is sarcoidosis, and he has extensive experience in the diagnosis and treatment of sarcoidosis in all of its forms, and the management of consequences of this systemic disease. The Sarcoidosis Clinic often serves to coordinate management of patients with multi-organ involvement with sarcoidosis, and to this end Dr. Chen actively maintains clinical and research collaborations with Cardiology, Cardiovascular Nuclear Medicine, Neurology, and Ophthalmology. Additionally, Dr. Chen participates as a Physician Champion in the Johns Hopkins Health System Epic project to improve the safety and quality of care of critically ill patients through optimization of the electronic medical record. His work involves developing systems-based approaches to complex management issues, including sepsis and severe alcohol withdrawal. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Sarcoidosis, Neurosarcoidosis, Lung Metastases, and Acute Interstitial Pneumonia. Dr. Chen is board certified in American Board Of Internal Medicine.

Dr. Liu is a pulmonary physician with additional expertise in allergy and immunology. He is an expert in the diagnosis and treatment of patients with severe asthma with a focus on developing new treatments for severe disease that has failed to respond to standard therapies. Dr. Liu is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Eosinophilic Asthma, Chronic Eosinophilic Pneumonia, Eosinophilic Pneumonia, Simple Pulmonary Eosinophilia, and Gastrostomy. Dr. Liu is board certified in American Board Of Allergy And Immunology and American Board Of Internal Medicine.

Dr. Gregory Diette is a professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in the Department of Epidemiology in the Johns Hopkins Bloomberg School of Public Health. He has over 20 years of experience diagnosing and managing complex and challenging pulmonary conditions. He is expert in the diagnosis and treatment of patients with common conditions such as asthma and COPD, as well as uncommon conditions such as allergic bronchopulmonary aspergillosis (ABPA), bronchiolitis obliterans, hypersensitivity pneumonitis and others. His practice includes evaluation of patients with unexplained shortness of breath and cough as well as patients with a variety of environmental lung conditions. In addition to his outpatient practice, Dr. Diette provides inpatient care on the pulmonary, critical care and internal medicine services. Dr. Diette earned his M.D. from the Temple University School of Medicine. He completed his residency at the Hospital of the University of Pennsylvania and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. He received his M.H.S. from the Johns Hopkins Bloomberg School of Public Health. His research interests include environmental impacts on lung disease, epidemiology of airway disease and chronic obstructive pulmonary disease. Dr. Diette is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Asthma, Allergic Bronchopulmonary Aspergillosis, Pulmonary Aspergilloma, and Aspergillosis.

Martin Sheridan is a Pulmonary Medicine provider practicing medicine in Baltimore, Maryland. Dr. Sheridan is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Lung Metastases, Asbestosis, Emphysema, and Chronic Obstructive Pulmonary Disease (COPD).

Khalid Puthawala is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Puthawala is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Pneumonia, and Emphysema. Dr. Puthawala is board certified in American Board Of Internal Medicine.

Dr. Putcha is a pulmonary and critical care physician. She is an expert in the diagnosis and treatment of lung disease (specifically obstructive lung diseases such as COPD and asthma), and in the care of critically ill patients in the Medical ICU. She is a member of the Lung Research Conference Planning Committee and provides teaching to medical students and residents at Johns Hopkins. Dr. Putcha is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Cerebral Hypoxia, and Asthma. Dr. Putcha is board certified in American Board Of Internal Medicine.

Dr. Ann Marie Parker is an instructor of medicine at the Johns Hopkins University School of Medicine. Her clinical focus is in pulmonary and critical care medicine, with a special interest in critically ill oncology patients as well as delirium and rehabilitation in the ICU. She earned her M.D. at the University of Maryland School of Medicine. She completed her residency at the University of Maryland Medical Center and a fellowship in pulmonary and critical care medicine at Johns Hopkins. Dr. Parker joined the Johns Hopkins faculty in 2016. Dr. Parker is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Long Haul COVID, Acute Respiratory Distress Syndrome (ARDS), Severe Acute Respiratory Syndrome (SARS), COVID-19, and Pancreaticoduodenectomy. Dr. Parker is board certified in American Board Of Internal Medicine.

Dr. Philip (Flip) Smith joined the faculty of the Johns Hopkins University School of Medicine in 1977. He is a pulmonary and critical care trained physician. He is an expert in the diagnosis and treatment of sleep and breathing disorders and in the care of critically ill patients. In 1977, Dr. Smith became the Director of the Medical Intensive Care Unit at Johns Hopkins Bayview Medical Center (formerly Baltimore City Hospitals). He then established the Adult Sleep Clinic in 1980. Dr. Smith earned his M.D. from the Tulane University School of Medicine. He completed his residency at Johns Hopkins Bayview Medical Center and performed a fellowship in pulmonary medicine at Johns Hopkins Medicine. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Obstructive Sleep Apnea, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Chronic Obstructive Pulmonary Disease (COPD). Dr. Smith is board certified in American Board Of Internal Medicine.

Dr. Nancy Li Schoenborn is an associate professor of medicine at Johns Hopkins University School of Medicine. Her clinical expertise is geriatric medicine and gerontology. Dr. Schoenborn earned her M.D. from Johns Hopkins University School of Medicine. She completed her residency in medicine and a fellowship in geriatric medicine and gerontology from Johns Hopkins Bayview Medical Center. Dr. Schoenborn is nationally and internationally renowned for her research on incorporating patient perspectives and overall health trajectories in individualized decision-making and communication with older patients. Her research has been funded by the National Institute on Aging, the American Cancer Society, the American Geriatrics Society, and the John A. Hartford Foundation. Her research findings have been published in high impact journals such as JAMA Internal Medicine and JAMA Oncology. She was named the Outstanding Junior Investigator of the Year by the American Geriatrics Society in 2019. Dr. Schoenborn is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. Her clinical expertise encompasses Dementia, Familial Hypertension, Hypertension, Colonoscopy, and Endoscopy. Dr. Schoenborn is board certified in American Board Of Internal Medicine.

Dr. Galiatsatos is a pulmonary and critical care medicine physician. He is an expert in the diagnosis and treatment of obstructive lung disease, tobacco cessation, and in the care of critically ill patients in the Medical ICU. He is a member of the Obstructive Lung Disease Group at Johns Hopkins, oversees the Tobacco Treatment Clinic and provides teaching to medical students and residents at Johns Hopkins. Dr. Galiatsatos is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Pulmonary Arteriovenous Fistula, Chronic Obstructive Pulmonary Disease (COPD), COVID-19, and Severe Acute Respiratory Syndrome (SARS). Dr. Galiatsatos is board certified in American Board Of Internal Medicine.

Dr. Hansel is a pulmonary and critical care medicine physician. She is an expert in the diagnosis and treatment of obstructive airway diseases, including asthma and chronic obstructive pulmonary disease (COPD), and care of patients in the Medical ICU. Dr. Hansel is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Asthma, Bronchitis, and Endoscopy. Dr. Hansel is board certified in American Board Of Internal Medicine.

Dr. Belz is a specialist in Pulmonary and Critical Care Medicine. He is Director of Bronchiectasis at the Johns Hopkins Center for Nontuberculous Mycobacteria and Bronchiectasis. He is an expert in the care of patients with bronchiectasis, asthma, COPD, and NTM pulmonary disease, and in the care of critically ill patients in the ICU. His research is dedicated to decreasing health disparities in the treatment of obstructive lung diseases such as COPD and bronchiectasis. He participates in clinical trials researching new treatments for bronchiectasis and NTM lung disease. He provides teaching to medical students, residents, and fellows at Johns Hopkins. Dr. Belz is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, and Cystic Fibrosis. Dr. Belz is board certified in American Board Of Internal Medicine.

Matthew Lammi, MD MSCR is an Associate Professor of Medicine and part of the Interstitial Lung Disease (ILD) Program. Dr. Lammi obtained his medical degree from Temple University School of Medicine and did his internal medicine, pulmonary, and critical care training at Temple University Hospital. He then joined the faculty at LSU in New Orleans, where he served as the Director of the Comprehensive Pulmonary Hypertension Center. He joined Johns Hopkins in 2023. He currently serves as the Associate Director of the Johns Hopkins Pulmonary Fibrosis Foundation Care Center and is the Associate Program Director for the Advanced Lung Disease Fellowship. His research focuses on the intersection between ILD and pulmonary hypertension, particularly in patients with systemic sclerosis. He is currently a co-Principal Investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is active in numerous societies and serves as the Chair of the Research Committee for the Pulmonary Hypertension Association. Dr. Lammi is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Sarcoidosis, Systemic Sclerosis (SSc), Interstitial Lung Disease, and Lung Transplant. Dr. Lammi is board certified in American Board Of Internal Medicine.

Dr. Neptune is a pulmonary, critical care physician with expertise in genetic disorders of the matrix with pulmonary manifestations. She is also skilled in the management of patients with advanced obstructive lung disease, especially emphysema. Dr. Neptune has extensive expertise in the diagnosis and management of the pulmonary complications of Marfan Syndrome, Loeys-Dietz Syndrome, vascular Ehlers Danlos Syndrome and other matrix disorders and serves on the Professional Advisory Board of the Marfan Foundation. She is also an expert on tobacco dependence and is the Vice-Chair of the Tobacco Action Committee of the American Thoracic Society. Dr. Neptune earned her M.D. from Harvard Medical School. She completed her residency and performed a fellowship in pulmonary and critical care at the University of California, San Francisco. She also performed a fellowship in genetics at Johns Hopkins. Her research interests include therapeutic strategies in Marfan syndrome; mechanisms and prevention of progression of COPD; and hepatocyte growth factor signaling in airspace homeostasis. Dr. Neptune is committed to creating a diverse research community and clinical workforce. She is involved in multiple diversity initiatives at Johns Hopkins and the American Thoracic Society. She is also involved in increasing awareness of tobacco dependence and the needed regulatory policies. Dr. Neptune serves on the Compliance Compensation Subcommittee for the Department of Medicine. Dr. Neptune is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), Acute Interstitial Pneumonia, Interstitial Lung Disease, and Emphysema. Dr. Neptune is board certified in American Board Of Internal Medicine.

Dr. Fawzy is a pulmonary and critical care physician. He is an expert in the diagnosis and treatment of lung disease with a particular focus on asthma and COPD (emphysema and chronic bronchitis) and in the care of critically ill patients in the Medical ICU. Dr. Fawzy earned his M.D. from Stony Brook University. He completed his residency at Boston University Medical Center and fellowship in pulmonary and critical care medicine at Johns Hopkins University. Dr. Fawzy joined the Johns Hopkins faculty in 2020, and is supported by the NIH to conduct clinical and translational research investigating the role of platelet phenotypes in COPD. Dr. Fawzy is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Cerebral Hypoxia, Emphysema, and Bronchitis. Dr. Fawzy is board certified in American Board Of Internal Medicine.

Anna Gersten is a Pulmonary Medicine provider practicing medicine in Baltimore, Maryland. Dr. Gersten is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, and Lung Metastases. Dr. Gersten is board certified in American Board Of Internal Medicine.